PQ 509
509. Deputy Tony McLoughlin asked the Minister for Health the position in regard to providing new drugs for cystic fibrosis patients here, in view of the recent submission of Vertex to the HSE, which would ensure access to Kalydeco and Orkambi for all eligible patients; if the HSE will expedite their process of decision-making; his views on whether the HSE is doing all that it can to ensure patients can access these medicines as soon as possible; and if he will make a statement on the matter. [16248/17]
Introduced
4 April 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
4 April 2017
Summary
509. Deputy Tony McLoughlin asked the Minister for Health the position in regard to providing new drugs for cystic fibrosis patients here, in view of the recent submission of Vertex to the HSE, which would ensure access to Kalydeco and Orkambi for all eligible patients; if the HSE will expedite their process of decision-making; his views on whether the HSE is doing all that it can to ensure patients can access these medicines as soon as possible; and if he will make a statement on the matter. [16248/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Drugs Payment Scheme Coverage
Drugs Payment Scheme Coverage
xml · EN · 4 April 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-04-04/509/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-04-04/pq_509